IMC closes acquisition of Trichome

18 March 2021

On March 18, 2021, IM Cannabis Corp. ("IMC") (CSE: IMCC) (NASDAQ: IMCC) announced the closing of its acquisition of Trichome Financial Corp. ("Trichome"), previously announced on December 30, 2020. The acquisition was completed pursuant to a plan of arrangement under the Business Corporations Act (Ontario).

IMC is a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel, Germany and Canada. As a result of this acquisition, IMC will enter the Canadian recreational cannabis market and launch its North American expansion strategy through Trichome's wholly-owned subsidiary, Trichome JWC Acquisition Corp. d/b/a JWC. IMC seeks to establish itself as a global leader in the adult-use recreational and medical cannabis sectors.

Gowling WLG advised IMC with respect to this acquisition with a team that included Peter Simeon, Jacob Cawker, Josh Almario, Ryan Cohen and Adam Sherman (corporate) and Paul Carenza (tax), assisted by student-at-law Blair Somerville.


NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.